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The identity of the Cu(I) binding ligands at Met-X3-Met site of AcaS
and its role into the affinity and structural properties of the
interaction were elucidated by NMR spectroscopy. We provide
evidence that the source of ligands for Cu(I) binding to the Met-
X3-Met site comes from the N-terminal acetyl group and the Met-1,
Asp-2 and Met-5 residues. From the study of site-directed mutants
and synthetic peptide models of aS we demonstrated the critical
role played by Met-1 and Met-5 residues on the binding affinity of
the Cu(I) complex, acting as the main metal anchoring residues.
While having a more modest impact in the affinity features of Cu(I)
binding, as compared to the Met residues, the N-terminal acetyl
group and Asp-2 are important in promoting local helical conformations,
contributing to the stabilization of these structures by favoring Cu(I)
binding.
Misfolding and aberrant self-assembly of proteins are considered
key molecular events in several neurodegenerative disorders such
as Creutzfeldt–Jakob’s disease, Alzheimer’s (AD) and Parkinson’s
disease (PD).1,2 Although these structural transformations have
been observed for a range of proteins, the mechanisms behind
the self-assembly of proteins into fibrillar deposits remain
often unknown.
Parkinson’s disease, the second most prevalent neuro-
degenerative disease after AD,3 is characterized by the progressive
degeneration of dopaminergic neurons in the substantia nigra
pars compacta affecting motor and non-motor functions.4
A hallmark of PD is the intraneuronal aggregation of the protein
a-synuclein (aS) into amyloid fibrillar formations.5,6 a-Synuclein
is an intrinsically disordered protein (IDP) making up 1% of
total brain-soluble proteins in humans and may play roles in
uptake, storage, recycling of neurotransmitter vesicles and
maintenance of dopamine.7–9 The protein comprises 140 amino
acid residues (Fig. 1), which constitute the amphipathic region
at the N-terminal region (resides 1–60), the hydrophobic non-
amyloid-b component (NAC) region (residues 61–95), and the
acidic region at the C-terminal region (96–140). In solution, the
NAC region tends to be partially shielded from the solvent,
induced by transient intramolecular interactions that delay
intermolecular aggregation.10,11 However, in disorders such as
PD or dementia aS may complex with Lewy bodies and adopt
conformations that trigger toxicity and neuronal cell death,
reflected by the presence of amyloid fibrillar aggregates.12,13
Transition metal ion homeostasis (copper, iron, zinc) plays
an important role in neurodegenerative disorders, because
Fig. 1 Primary sequence of full-length aS. Met and His residues acting as
main anchoring residues in Cu(I) binding sites are highlighted.
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Protein–metal interactions play an important role in aS aggregation and
might link the pathological processes of protein aggregation, oxidative
damage and neuronal cell toxicity. Advances in the bioinorganic chem-
istry of Parkinson’s disease require that details of the binding specificity
of Cu(I) to the protein a-synuclein and its conformational consequences
to be better understood. In this work we have elucidated identity of the
Cu(I) binding ligands at the Met-X3-Met Motif of AcaS and its role into the
affinity and structural properties of the interaction. Our findings might
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these ions are considered as one of the possible factors leading
to protein aggregation.14–16 Indeed, metal–protein interactions
often impact the kinetics of amyloid aggregation and the
neurotoxicity of protein aggregates; particularly, this has been
demonstrated for the case of copper and zinc interactions with
the amyloid beta peptide,17–19 associated to AD.
Protein–metal interactions play an important role in aS
aggregation15,20 and might link the pathological processes of
protein aggregation, oxidative damage and neuronal cell
toxicity.14,16,21 A recent study demonstrated that under aerobic
conditions, iron(II)-mediated O2 chemistry locks aS into an
oligomeric conformation that prevents a parallel b-sheet fold
that would normally progress into fibrils, suggesting that the
elevated toxicity of the iron-aS coupling could be linked to the
antiparallel right-twisted conformation of aS that occurs
following iron(II) coordination in the presence of O2.
22 It was
also shown recently that calcium mediates distinct pathways of
aS aggregation, involving interfibrillar aggregation and formation
of large, toxic aggregates as the final products.23,24 Notably,
copper was shown to be the most effective metal ion promoting
aS fibril formation,15,25 subsequently causing cytotoxicity26,27 or
seeding aS aggregation.28 Adding biological relevance to these
findings, brain concentrations of copper appears dysregulated in
patients with PD, suggesting that a positive correlation might be
established between an increase of copper levels and disease
severity.29–34
The ability of copper to accept or donate electrons implicates
it in the production of reactive oxygen species, an established
pathway of PD.35 This mechanism is a highly selective, site-
specific process that involves interactions of the protein with
both oxidation states of the copper ion.15,36–43 Added to the
abundant evidence revealing that aS undergoes N-terminal
acetylation in vivo (AcaS),44,45 it was recently reported that this
modification of aS abolishes high-affinity Cu(II) binding.46 Since
copper ions are predominantly found in their Cu(I) state in the
reducing environment of living cells, characterization of the
physiologically relevant AcaS–Cu(I) complexes is important.
NMR-based studies revealed that the main anchoring groups
for Cu(I) binding – Met1/Met5 (site 1), His50 (site 2) and
Met116/Met127 (site 3)- were preserved in the acetylated form
of the protein42,47–49 (Fig. 1). In addition, formation of the
AcaS–Cu(I) complex at site 1 stabilizes local conformations that
contain substantial a-helical secondary structure and have
restricted mobility.42 Linked to the fact that the Met-X3-Met
motif (site 1) at the N-terminus of AcaS resembles motifs found
in helical copper transport proteins, the formation of AcaS–
Cu(I) complex at site 1 might have physiologically relevant
implications in processes related to metal-transport, membrane
binding or protein aggregation, which are enhanced by increased
a-helical content at the N-terminus of the protein.
With regard to the coordination environment of Cu(I) in site
1 of the aS protein, EXAFS investigations revealed a 2S2O/N
coordination sphere for the metal ion, thus indicating the
presence of a four coordinated Cu(I) ion, probably with a tetra-
hedral geometry.37 While the role of the two thioether groups of
Met-1 and Met-5 as metal anchoring groups for Cu(I) binding to
site 1 was demonstrated,41,44,46,50,51 the identity of the residues
providing the oxygen/nitrogen ligands is less well known. From
NMR structural calculations obtained for the complex between
Ag(I) and the 1–15 peptide of b-synuclein (bS), an homologue
protein of aS that coordinates Cu(I) through Met residues at
position 1, 5 and 10, it was proposed that Asp residue at position
2 of bS might act as a potential source for the establishment of a
Cu–O bond.37 Based on these data, a similar role was proposed for
Asp-2 in Cu(I) coordination to the protein aS.37 Regarding the
additional oxygen/nitrogen atom bound to Cu(I) in site 1, it was
attributed to a water or acetonitrile molecule.
In this work we sought to delineate the coordination environ-
ment and binding specificity of Cu(I) to the Met-X3-Met motif of
the protein aS. The identity of the Cu(I) binding ligands and its
role into the affinity and structural properties of the interaction
was investigated by the combined application of NMR spectro-
scopy and the design of site-directed mutants and synthetic
peptide models of the protein. Previously, we demonstrated the
role of Met-1 and Met-5 as anchoring residues for the binding of
Cu(I) to the protein aS.49 In order to assess the role of N-terminal
acetylation and Asp-2 on metal coordination to the Met-X3-Met
site, we investigated the details of Cu(I) binding to the synthetic
peptide Ac-1MDVFMK6 (P1AS) and its non-acetylated variants
P1AS and D2A P1AS, and compared their Cu(I)-binding features.
The backbone amide regions in the 1D 1H NMR spectra of the
different peptide species in the absence and presence of Cu(I)
are shown in Fig. 2A–F. This spectral region contains well-
resolved resonances and thus constitutes an excellent probe to
analyze the metal–peptide interaction process. Whereas the
amide resonances of Met-1 and Asp-2 cannot be detected in
the experiments performed with the non N-acetylated peptide forms
because of solvent-exchange effects, the signals from these residues
become detectable upon acetylation of the N-terminus (Fig. 2E, F
and Fig. S1, ESI†).
As reflected by Fig. 2E and F resonances of amide protons
corresponding to Met-1 in the Ac-P1AS peptide were clearly
most affected by the interaction with the metal ion than those
corresponding to Met-5, indicating that the interaction of the
metal ion with Met-1 is favored. Notably, the effects of Cu(I)
binding on the amide resonances of Met-5 were more pronounced
in the variants P1AS (Fig. 2C and D) and D2A (Fig. 2A and B)
compared to the Ac-P1AS peptide, suggesting that acetylation at the
N-terminus and/or the presence of an Asp residue at position 2
influences Cu(I) binding at site 1.
We further characterized the binding interaction of Cu(I)
with the P1AS variants of Fig. 2 by inspecting the chemical
shifts changes induced by Cu(I) binding on the S-CH3 methyl
resonances belonging to Met residues. To detect the characteristic
He proton resonances corresponding to the S-CH3 groups of
Met-1 and Met-5 we performed 1D 1H NMR experiments (data
not shown). Consistent with the results described above, the
degree of perturbation induced by one equivalent of Cu(I) on
the S-CH3 resonances of Met-1 decreases in the order: Ac-P1AS
(Dd = 0.14 ppm) 4 P1AS (Dd = 0.11 ppm) 4 D2A P1AS
(Dd = 0.08 ppm), giving further support to the role of N-terminal
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coordination at site 1. Overall, these results confirm that the
effects observed on the amide groups of the peptide variants in
the presence of Cu(I) reflect the direct interaction of the metal
ion with the sulfur atoms of the Met-1 and Met-5 residues,
consistent with the binding preference of Cu(I) to coordinate
sulfur atoms of Met residues in metalloproteins.
Next, to quantify the impact of these changes on the affinity
features of Cu(I) binding to the Met-X3-Met site, we determined
the dissociation constants of Cu(I) complexes with the P1AS
variants studied. The resonances corresponding to the S-CH3
groups of Met-1 and Met-5 were well-resolved over the entire
Cu(I) titration experiments and thus well-suited for calculation
of the dissociation constant. Fig. S2 (ESI†) shows the binding
curves of Cu(I) to Ac-P1AS and the P1AS and D2A P1AS variants.
The derived conditional dissociation constants (cKd1) for the
complexes of Cu(I) with Ac-P1AS, P1AS and D2A P1AS variants
were 4.8  0.7 nM, 8.5  0.5 nM and 13.4  1.0 nM,
respectively. From the estimation of the conditional affinity
for the complexes of Cu(I) with the M5I and M1I P1AS peptide
variants the values 65  5 nM and 163  10 nM were obtained,
respectively.49 These results allow us to conclude that: (i) the
binding affinity for Cu(I) decrease in the order Ac-P1AS 4
P1AS 4 D2A P1AS 4 M5I P1AS 4 M1I P1AS; (ii) Met-1 and
Met-5 residues act as the main anchoring moieties for Cu(I)
binding to site 1, providing S–Cu binding modes; (iii) N-terminus
acetyl group and Asp residue in position 2 sequence play a more
modest role in terms of Cu(I) binding affinity, acting as potential
sources for the establishment of Cu–O binding modes.
To confirm the findings derived from our analysis of Cu(I)
binding to peptide models, we then analyzed the structural and
affinity features of the Cu(I) complex with the Met-X-Met motif
in the N-terminal region of the protein aS. To this purpose, we
used 15N isotopically enriched AcaS and the M5I/H50A and D2A
mutants. The D2A mutant of aS is not a substrate for the NatB
acetylase and thus lacks that post-translational modification,
being referred as D2A aS further on.
The Cu(I) complexed states of the AcaS protein and its
M5I/H50 AcaS and D2A aS mutant species were analyzed by
2D NMR spectroscopy (Fig. 3 and 4). As reported previously,
upon titration of 15N-enriched AcaS with increasing concentrations
of Cu(I), the 1H–15N heteronuclear single quantum correlation
(HSQC) spectra retained the excellent resolution of the uncom-
plexed protein but demonstrated large chemical shift changes
in a discrete number of amide resonances belonging to residues
involved in Cu(I) binding at site 1 (Fig. 3A). As shown in Fig. 4,
the resonances corresponding to amide groups of residues
involved in Cu(I) binding to site 1 of the D2A aS protein were
affected to a lesser extent by the presence of the metal ion,
whereas almost no changes were observed in that set of signals
for the M5I/H50 AcaS mutant. From these experiments, the
conditional affinity for Cu(I) binding at site 1 in AcaS was cKd1 =
3.9  1.0 nM (Fig. 3B), consistent with previous studies.42,50
Interestingly, the value reported for the Cu(I)-complex in the
non-acetylated protein was cKd1 = 7.8  1.0 nM,48 in line with the
affinity differences found for Cu(I) binding to the N-acetylated and
free amine P1AS peptides. The value of cKd1 for complexation of
Cu(I) to the Met-X3-Met site in M5I/H50A AcaS and the D2A aS were
63  5 nM and 14  2 nM, respectively. Overall, these data
demonstrate that the affinity features observed for Cu(I) binding
in the synthetic peptide models are preserved in the proteins.
The structural implications of Cu(I) binding to these proteins
were also evaluated in terms of the dynamic properties of their
Cu(I) complexed forms. To this purpose, we measured 15N R1
and R2 relaxation rates. This set of experiments was first
measured on the free state of the AcaS protein and the M5I/
H50A AcaS and D2A aS mutants (Fig. 5). In all cases, the
relaxation parameters showed a similar sequence dependence,
with lower values at the termini of the protein and a plateau at
the center of the relaxation profile, showing R1 values between
1.2 and 1.7 s1 and R2 values between 2.0 and 4.0 s
1 (Fig. 5).
Complexation with Cu(I) resulted in a slight increase in the R1
values for the 1–10 segment of the AcaS sequence (mean R1
values of 1.5 s1 and 1.9 s1 in the free and complexed protein,
Fig. 2 NMR analysis of Cu(I) binding to aS synthetic model peptides.
1D 1H NMR spectra (7.5–8.5 ppm) of D2A P1AS (A and B), P1AS (C and D)
and Ac-P1AS (E and F) peptides in the absence (black) and presence (green)
of 1 equiv. of Cu(I). In all cases, the addition of EDTA abolished the changes
induced by the metal ion, confirming the reversibility of the interaction
(data not shown). All experiments were recorded on 50 mM peptide
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respectively); however, more pronounced deviations were found
in the R2 values (mean R2 values of 2.2 s
1 and 5.8 s1 for the
free and complexed protein, respectively). These data indicate
restricted local sampling in the pico- to nanosecond time scale
for the 1–10 segment of AcaS–Cu(I) relative to the free protein,
reflecting the loss of flexibility due to the stabilization of local
conformations with a-helical secondary structure, as previously
published.42,50 On the other hand, the slight increase of R2
values around His 50 and Met-116/127 residues in AcaS–Cu(I)
reflects the low affinity interaction and fast exchange of the
metal ion at these secondary sites.42,50 Interestingly, the back-
bone dynamic profiles of the Cu(I) complexed states of M5I/H50
AcaS and D2A aS measured under the same experimental
conditions do not show changes in their R1 values relative to
their metal-free states. As shown in Fig. 5, the differences
observed between the R2 profiles of AcaS–Cu(I), M5I/H50
AcaS–Cu(I) and D2A aS–Cu(I) states are centered at the 1–10
segment. The R2 values in the 1–10 segment of the D2A aS–Cu(I)
are increased to a lower extent compared to the AcaS–Cu(I)
state, whereas only a slight deviation is observed for the R2
values in the M5I/H50 AcaS–Cu(I) form. These differences
correlate well with the different affinities determined for the
binding of the metal ion at these sites; however, the lower R2
values for the D2A aS–Cu(I) form might be also reflecting a
small increase of a-helical propensity near the N-terminus,
induced by the interaction with Cu(I) at the Met-X3-Met site.
These results motivated us to evaluate the Cu(I) protein com-
plexes in terms of their conformational properties. 3JHN-Ha
couplings are reliable quantitative reporters of the time-
averaged distribution of the backbone torsion angles, j, and
are frequently used to probe the propensity of intrinsically
disordered proteins to sample different regions of conformational
space. Therefore, we measured residue-specific 3JHN-Ha couplings
in both free and copper-bound states of these proteins (Fig. S3,
ESI†). With the exception of the decrease in 3JHN-Ha for the first 10
residues of AcaS upon Cu(I) binding, the values measured for the
two forms of the M5I/H50A AcaS and D2A aS proteins were
essentially indistinguishable. With an averaged 3JHN-Ha of 4.5 Hz
expected for an ideal a-helix and a 3JHN-Ha of B7 Hz for random
coil, our results indicate that a conformational transition toward
increased a-helix structures is clearly observed only for the
AcaS–Cu(I) form.
These results allow us to conclude that the N-terminal acetyl
group and the Met-1, Asp-2 and Met-5 residues provide the
binding ligands for the coordination environment of Cu(I) at
the Met-X3-Met site of AcaS. Met-1 and Met-5 residues are
critical for the binding affinity of the Cu(I) complex, acting as
the main anchoring residues for metal binding. While having a
more modest impact in the affinity features of Cu(I) binding at
this site, as compared to the Met residues, the N-terminal acetyl
group and Asp-2 are important in promoting local helical
conformations, contributing to the stabilization of these structures
by favoring Cu(I) binding. Thus, the increased helicity in AcaS–
Cu(I) can be rationalized by stabilization of the helix macrodipole
and formation of energetically more favorable hydrogen bond
interactions triggered by the removal of the a-amino positive
charge upon acetylation, by the role of Asp-2 diminishing the
dipole moment to its N-terminus and by the Cu(I)-induced
structural rearrangement of Met-1 and Met-5 side chains,
respectively.51,52
Our study demonstrates that perturbing the coordinating
residues involved in Cu(I) binding at site 1 of aS has an effect
also in the redox properties of the complex. Specifically, for the
series of peptide and protein variants studied here, the trend in
Cu(I) binding affinity follows: Ac-P1AS 4 P1AS 4 D2A-P1AS 4
M5I-P1AS 4 M1I-P1AS. Consistent with our results and with
previous findings,49 the Met residues play a key role in Cu(I)
coordination and affinity features, having Met-1 a more important
role in stabilizing Cu(I) binding. In terms of the redox properties of
the site, the decrease in Cu(I) binding affinity observed for the M1I
Fig. 3 NMR analysis of Cu(I) binding to AcaS. (A) Overlaid 1H–15N HSQC
spectra of AcaS in the absence and presence of increasing Cu(I) concentrations.
From blue to red: 0, 1.0, 3.0 and 5.0 equiv. of Cu(I). Most-affected residues
involved in Cu(I) binding to the Met-X3-Met site are labeled. (B) Binding curves of
Cu(I) to the Met-X3-Met site of AcaS as monitored by the average change in the
mwDd for 1H and 15N of most affected amide resonances: Met-1 ( ), Asp-2 ( ),
Val-3 ( ), Phe-4 ( ), Met-5 ( ), Lys-6 (’) and Gly-7 ( ). Curves represent the
fit to a model incorporating complexes of Cu(I) into three classes of
independent, non-interactive binding sites, using the program DynaFit.
Experiments were recorded at 15 1C using 15N isotopically enriched AcaS
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modification translates into an 76 mV decrease in the reduction
potential (53 mV for the M5I mutant), consistent with previous
reports.53 A new finding from this study is that Asp-2 also plays a
role in Cu(I) binding; the D2A modification causes a B1.5 fold
decrease in binding affinity for Cu(I), which would translate into a
decrease of B15 mV in the reduction potential, if this mutation
were not to impact Cu(II) binding affinity as it does (Table S1,
ESI†). While having a more modest impact in the redox properties
of site 1, Asp-2 is certainly also playing a role in stabilizing Cu(I)
coordination to aS. Finally, the acetylation of the N-terminal group
causes a B1.7 fold increase in Cu(I) binding affinity, which would
translate into a B17 mV increase in the reduction potential of the
complex, if it were not to impact Cu(II) binding affinity. However, it
is important to note that acetylation also has a drastic impact in
Cu(II) coordination, since it abolishes metal binding at this site.46
Thus, the combined effect of acetylation of the N-terminal group is
expected to stabilize Cu(I) while significantly destabilizing Cu(II),
contributing to a significant increase of B258 mV of the reduction
potential of the site, as compared to the non-acetylated form
(Table S1, ESI†). Overall, these results underscore the important
role that acetylation and the Asp-2 residue play together to stabilize
the reduced form of the aS–Cu complex.
Fig. 4 NMR analysis of Cu(I) binding to the M5I/H50A and D2A protein variants. (A) Overlaid 1H–15N HSQC spectra of M5I/H50A AcaS in the absence
(black) and presence (orange) of 1 equiv. of Cu(I). (B) Overlaid 1H–15N HSQC spectra of D2A aS in the absence (black) and presence (orange) of 1 equiv. of
Cu(I). For comparative purposes with AcaS-Cu(I), residues well-isolated and involved in Cu(I) binding to site 1 are labeled. Experiments were recorded at
15 1C using 15N isotopically enriched protein (50 mM) samples dissolved in Buffer A.
Fig. 5 15N relaxation parameters of aS variants and its Cu(I) complexes. R1 and R2, relaxation rates of the proteins AcaS, M5I/H50A AcaS and D2A aS in the
absence (black) and presence (green) of Cu(I). Experiments were recorded at 15 1C using 15N isotopically enriched protein (200 mM) samples dissolved in
Buffer A in the absence and presence of 2 equivalents of Cu(I). The increase of R2 values around His-50 and Met-116/127 residues in AcaS-Cu(I) reflects
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Another important impact of the acetylation of aS is the
promotion of local helical conformation upon Cu(I) binding.42,50
It has been reported that chemical induction of alpha-helical
conformation in aS by using fluorinated solvents increases the
reduction potential of the aS–Cu complex by B90 mV, possibly
stabilizing the Cu(I) form.54 From this shift, an increase in Cu(I)
binding affinity of an order of magnitude was estimated for the
alpha-helical aS form, as compared to the unstructured state. In
line with this, a more recent work reported that Cu(I) binding to
the 1–15 fragment of aS in the presence of SDS micelles resulted
in a dissociation constant two orders of magnitude smaller than
that found for the complex with the full protein in aqueous
buffer.47 On the other hand, our data does not show such a
dramatic change in Cu(I) affinity upon induction of a-helical
conformations by complexation of the metal ion to the
N-acetylated form of the protein. Although this could be attributed
to a shorter length and/or the more dynamic (transient) properties
of helical structures induced by aS–Cu(I) complexation at the
Met-X3-Met site, as compared to that induced by the fluorinated
solvent or SDS micelles, studies performed under more physiolo-
gically relevant conditions are clearly needed to evaluate the role of
local conformations over the affinity and redox potential properties
of aS–Cu(I) complexes.
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